CD68+ macrophages in the stroma and total areas were markedly higher in COPD patients than in non-COPD patients; although the difference was not significant in the tumor area, it showed a favorable statistical trend in COPD patients compared to non-COPD patients (Figure 5A). This evidence concerns the gene CD68 and neoplasm.